Type-2 diabetes mellitus: does insulin provision in primary care improve metabolic control?
Comerma Méndez, A.; Agustí Corredor, J.; Mas Marquès, M.; Girona Bastús, R.
Atencion Primaria 33(1): 54-55
2004
ISSN/ISBN: 0212-6567 PMID: 14746751 Document Number: 579621
Document emailed within 1 workday
Related Documents
Roos, A.N.; Meinders, A.E. 1989: Does an insulin pen improve the metabolic control of type 1 diabetes mellitus if added to conventional treatment? Netherlands Journal of Medicine 34(3-4): 116-125Jungmann, E.; Helling, T.; Jungmann, G.; Mertens, C.; Snelting, U. 2001: Intensified conventional insulin therapy in patients with type 2 diabetes mellitus. Positive long-term effects of insulin lispro on metabolic control and microalbuminuria Fortschritte der Medizin. Originalien 118(4): 141-146
Davì, G.; Belvedere, M.; Vigneri, S.; Catalano, I.; Giammarresi, C.; Roccaforte, S.; Consoli, A.; Mezzetti, A. 1996: Influence of metabolic control on thromboxane biosynthesis and plasma plasminogen activator inhibitor type-1 in non-insulin-dependent diabetes mellitus Thrombosis and Haemostasis 76(1): 34-37
Van der Riet, A.A.; Harteloh, P.P.; Rutten, F.F.; Jonker, J.J. 1995: Adjustment to insulin of patients with type Ii diabetes mellitus in primary care; good results at low cost Nederlands Tijdschrift Voor Geneeskunde 139(10): 508-512
Jungmann, E.; Krüger, K.; Semler, B.; Haak, T.; Scherberich, J.; Schumm-Draeger, P.M.; Usadel, K.H. 1994: The nephroprotective effect of ramipril. Effect on blood pressure and metabolic control in insulin-treated patients with type-2 diabetes mellitus Fortschritte der Medizin 112(3): 39-42
Parrilla Saldaña, J.; Suffo Aboza, J.A.; Coballa Rins, R.; Gil Casteliano, J.; Díaz Esteban, A.M. 1996: Quality control in non-insulin dependent diabetes mellitus. Comparative study in 2 primary care centers Revista de Enfermeria 19(219): 24-31
Abdelaziz, A.B.; Soltane, I.; Gaha, K.; Thabet, H.; Tlili, H.; Ghannem, H. 2006: Predictive factors of glycemic control in patients with type 2 diabetes mellitus in primary health care Revue d'Epidemiologie et de Sante Publique 54(5): 443-452
Rosak, C.; Hövelmann, R.; Martin, J. 2003: Type 2 diabetes -- higher doses of metformin improve metabolic control MMW Fortschritte der Medizin 145(21): 39
Torres Tamayo, M.; Lerman Garber, I.; Bravo Ríos, L.E.; Cardoso Saldaña, G.; Mendoza Morfín, F.; Zamora González, J.; Montero González, P.; Junco Lorenzana, E.; Posadas Romero, C. 1993: Metabolic control and the prevalence of dyslipidemia in children and adolescents with insulin-dependent diabetes mellitus Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 45(6): 545-552
Pacifico, A.; Cherchi, G.M.; Baggi, M.A.; Deiana, M.G.; Maioli, M. 1983: Changes in HDL subfractions in patients with type I diabetes mellitus before and after metabolic control Bollettino della Societa Italiana di Biologia Sperimentale 59(11): 1618-1624
Kotanko, P.; Heiss, H.; Wild, W.; Wach, P.; Wiesspeiner, G.; Skrabal, F. 1990: System for documenting and optimizing metabolic control in type i diabetes mellitus Biomedizinische Technik. Biomedical Engineering 35(Suppl 2): 181-182
González-Ortiz, M.; Martínez-Abundis, E. 1999: Maternal effect of Type 2 diabetes mellitus on insulin sensitivity and metabolic profile in healthy young Mexicans Diabetes Nutrition and Metabolism 12(1): 32-36
Chellingsworth, M.C.; Kendall, M.J.; Wright, A.D.; Singh, B.M.; Pasi, J. 1989: The effects of verapamil, diltiazem, nifedipine and propranolol on metabolic control in hypertensives with non-insulin dependent diabetes mellitus Journal of Human Hypertension 3(1): 35-39
Shen, C.-J.; Yin, Y.-Z.; Shu, R. 2008: The effect of initial periodontal therapy on metabolic control in type 2 diabetes mellitus Shanghai Kou Qiang Yi Xue 17(1): 6-9
Steiner, M.; Reinhardt, K.M.; Krammer, B.; Ernst, B.; Blann, A.D. 1994: Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control Thrombosis and Haemostasis 72(6): 979-984
Hayden, M.R.; Tyagi, S.C. 2002: Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus Jop: Journal of the Pancreas 3(4): 86-108
Duimel-Peeters, I.G.P.; Schulpen, G.J.C. 2007: Disease managemenet in type Ii diabetes mellitus: improving primary care Pflege Zeitschrift 60(8): 439-443
Bogatyreva, S.I.; Dzeranova, N.I.; Shlimovich, P.B. 1972: Content of immunoreactive insulin in the plasma and insulin sensitivity in patients with diabetes mellitus during the process of sulfanilamide compensation of metabolic disorders Problemy Endokrinologii 18(3): 22-25
Sunni, M.; Mays, R.; Kaup, T.; Nathan, B. 2011: Recognizing and managing type 2 diabetes mellitus in children: an algorithm for primary care providers Minnesota Medicine 94(8): 34-39
González-Ortíz, M.; Martínez-Abundis, E.; Cardona-Muñoz, E.G.; Lifshitz, A.; Quiñones-Galván, A. 1997: Metabolic profile and insulin sensitivity in healthy young Mexicans with a strong family history of non-insulin-dependent diabetes mellitus in the paternal branch Archives of Medical Research 28(3): 421-424